🇺🇸 Fixed Dose Combination "Etoshine MR" tablets in United States

998,879 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 147,201 reports (14.74%)
  2. Nausea — 118,083 reports (11.82%)
  3. Fatigue — 114,479 reports (11.46%)
  4. Off Label Use — 111,055 reports (11.12%)
  5. Diarrhoea — 104,707 reports (10.48%)
  6. Pain — 92,268 reports (9.24%)
  7. Headache — 89,216 reports (8.93%)
  8. Dyspnoea — 82,084 reports (8.22%)
  9. Vomiting — 70,617 reports (7.07%)
  10. Arthralgia — 69,169 reports (6.92%)

Source database →

Fixed Dose Combination "Etoshine MR" tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fixed Dose Combination "Etoshine MR" tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fixed Dose Combination "Etoshine MR" tablets in United States?

Dr. Vishwanath Karad MIT World Peace University is the originator. The local marketing authorisation holder may differ — check the official source linked above.